Moving toward disease modification in polycythemia vera

JP Bewersdorf, J How, L Masarova, P Bose… - Blood, 2023 - ashpublications.org
Polycythemia vera (PV) belongs to the BCR-ABL1–negative myeloproliferative neoplasms
and is characterized by activating mutations in JAK2 and clinically presents with …

Revisiting circulating extracellular matrix fragments as disease markers in myelofibrosis and related neoplasms

HC Hasselbalch, P Junker, V Skov, L Kjær… - Cancers, 2023 - mdpi.com
Simple Summary MPN blood cancers are characterized by elevated blood cell counts.
Chronic inflammation drives MPNs, which after 10–30 years, may lead to bone marrow …

Delivery of interferon β-encoding plasmid via lipid nanoparticle restores interferon β expression to enhance antitumor immunity in colon cancer

Y Yang, S Bo, L Liang, K Deng, L Bai, T Wang… - ACS …, 2024 - ACS Publications
Type I interferon (IFN-I) plays a critical role in host cancer immunosurveillance, but its
expression is often impaired in the tumor microenvironment. We aimed at testing the …

Therapeutic implications of the interplay between Interferons and ER in breast cancer

N Todorović-Raković, JR Whitfield - Cytokine & Growth Factor Reviews, 2024 - Elsevier
The involvement of interferons (IFNs) in various diseases, including breast cancer, has
sparked controversy due to their diverse roles in immunity and significant impact on …

[图书][B] Morbidity and childbirth in myeloproliferative neoplasms

AR Landtblom - 2023 - search.proquest.com
Myeloproliferative neoplasms (MPN) are a family of chronic hematologic cancers,
characterized by excess proliferation of myeloid cell lineages, or fibrosis of the bone marrow …